Filtered By:
Condition: Alzheimer's
Infectious Disease: Coronavirus
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 15 results found since Jan 2013.
Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research.
Abstract
1. Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus infectious disease 2019 (COVID-19), which was first reported in Wuhan, China, in late December, 2019. Despite the tremendous efforts to control the disease, SARS-CoV-2 has infected 1,5 million people and caused the death of more than a hundred thousand people across the globe as of writing. Recently, Mao et al. [1] investigated the penetration potential of SARS-CoV-2 into the central nervous system in 214 patients. They reported that 36.4% of the patients had some neurologic findings which are ranged from nonsp...
Source: Current Neurovascular Research - May 21, 2020 Category: Neurology Authors: Bostanciklioglu M, Temiz E Tags: Curr Neurovasc Res Source Type: research
eAssist Dental Health Education Foundation Goes Over and Above to Drive Systemic Health
Helping patients help themselves stay their healthiest SALT LAKE CITY, Oct. 26, 2020 /PRNewswire/ -- eAssist Dental Solutions, the nation ' s leading provider of virtual insurance and patient billing services for dental offices, proudly launches its new Dental Health Education Foundation, a nonprofit organization on a mission to spread awareness of the importance of dental cleanings. This year COVID-19 has helped bring to the attention of the public the devastating impact of inflammation on the body. Specifically, that increased systemic inflammation – which can be caused by oral inflammation du...
Source: Dental Technology Blog - November 7, 2020 Category: Dentistry Source Type: news
Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma
In conclusion, luteolin can improve cognitive decline and enhance neuroprotection in neurodegenerative diseases, TBI, and stroke.
Source: BioFactors - October 24, 2020 Category: Biochemistry Authors: Duraisamy Kempuraj,
Ramasamy Thangavel,
Deepak D. Kempuraj,
Mohammad Ejaz Ahmed,
Govindhasamy Pushpavathi Selvakumar,
Sudhanshu P. Raikwar,
Smita A. Zaheer,
Shankar S. Iyer,
Raghav Govindarajan,
Premkumar Nattanmai Chandrasekaran,
Asgar Zaheer Tags: Review Article Source Type: research
How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis
Interstitial pneumonia was the first manifestation to be recognized as caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, in just a few weeks, it became clear that the coronavirus disease-2019 (COVID-19) overrun tissues and more body organs than just the lungs, so much so that it could be considered a systemic pathology. Several studies reported the involvement of the conjunctiva, the gut, the heart and its pace, and vascular injuries such as thromboembolic complications and Kawasaki disease in children and toddlers were also described. More recently, it was reported that in a sample of 214 SA...
Source: Frontiers in Psychiatry - November 16, 2020 Category: Psychiatry Source Type: research
500,000 Americans Now Dead from COVID-19 500,000 Americans Now Dead from COVID-19
The novel coronavirus is now the third leading cause of death in the U.S. -- behind heart disease and cancer, but ahead of accidents, respiratory diseases, stroke, Alzheimer ' s, and the flu.WebMD Health News
Source: Medscape Emergency Medicine Headlines - February 22, 2021 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news
Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma
In conclusion, luteolin can improve cognitive decline and enhance neuroprotection in neurodegenerative diseases, TBI, and stroke.
Source: BioFactors - October 24, 2020 Category: Biochemistry Authors: Duraisamy Kempuraj,
Ramasamy Thangavel,
Deepak D. Kempuraj,
Mohammad Ejaz Ahmed,
Govindhasamy Pushpavathi Selvakumar,
Sudhanshu P. Raikwar,
Smita A. Zaheer,
Shankar S. Iyer,
Raghav Govindarajan,
Premkumar Nattanmai Chandrasekaran,
Asgar Zaheer Tags: Review Article Source Type: research
The U.S. Death Rate Rose Significantly During the COVID-19 Pandemic
COVID-19 was the third-most-common cause of death in the U.S. in 2020, contributing to more than 375,000 deaths, and a 16% increase in the national death rate, according to provisional data published today by the U.S. Centers for Disease Control and Prevention (CDC).
All told, more than 3.3 million people in the U.S. died in 2020, for a rate of about 829 deaths per 100,000 people. That’s up from about 715 deaths per 100,000 people in 2019.
( function() {
var func = function() {
var iframe = document.getElementById('wpcom-iframe-cc2cb8dfd195b43a5d43643e9ec19ffa')
if ( iframe ) {
iframe.onload =...
Source: TIME: Health - March 31, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news
COVID-19 Infection and Circulating Microparticles —Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease
AbstractSevere acute respiratory syndrome corona virus-2 (SARS-CoV-2) due to novel coronavirus disease 2019 (COVID-19) has affected the global society in numerous unprecedented ways, with considerable morbidity and mortality. Both direct and indirect consequences from COVID-19 infection are recognized to give rise to cardio- and cerebrovascular complications. Despite current limited knowledge on COVID-19 pathogenesis, inflammation, endothelial dysfunction, and coagulopathy appear to play critical roles in COVID-19-associated cerebrovascular disease (CVD). One of the major subtypes of CVD is cerebral small vessel disease (C...
Source: Molecular Neurobiology - June 26, 2021 Category: Neurology Source Type: research
Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials
CONCLUSION: Based on the current evidence, piperine can be the potential molecule for treatment of disease, and its significance of this molecule in the clinic is discussed.PMID:35127957 | PMC:PMC8796742 | DOI:10.1186/s43088-022-00196-1
Source: Appl Human Sci - February 7, 2022 Category: Physiology Authors: Amit Kumar Tripathi Anup Kumar Ray Sunil Kumar Mishra Source Type: research
Cytokine storm and neuropathological alterations in patients with neurological manifestations of COVID-19
Curr Alzheimer Res. 2022 Sep 8. doi: 10.2174/1567205019666220908084559. Online ahead of print.ABSTRACTThe COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2), a respiratory pathogen with neuroinvasive potential. Neurological COVID-19 manifestations include loss of smell and taste, headache, dizziness, stroke, and potentially fatal encephalitis. Several studies found elevated proinflammatory cytokines such as TNF-α, IFN-γ, IL-6 IL-8, IL-10 IL-16, IL-17A, and IL-18 in severely and critically ill COVID-19 patients, which may persist even after apparent recovery from infection. Bioma...
Source: Current Alzheimer Research - September 12, 2022 Category: Neurology Authors: Christos Tsagkaris Muhammad Bilal Irem Aktar Youssef Aboufandi Ahmet Tas Abdullahi Tunde Aborode Tarun Kumar Suvvari Shoaib Ahmad Anastasiia Shkodina Rachana Phadke Marwa S Emhamed Atif Amin Baig Athanasios Alexiou Ghulam Md Ashraf Mohammad Amjad Kamal Source Type: research
